IL2 and acute myeloid leukemia: Bachanova et al.47 have reported that depletion of host regulatory T cells (Tregs) with IL-2-diptheria toxin enhances NK cell expansion and improves the efficacy of haploidentical NK cell therapy for refractory AML, with increased CR rates exceeding 50%.